Phase I/II Trial Assessing Bortezomib and Melphalan Combination Therapy for the Treatment of Patients With Relapsed or Refractory

http://www.100md.com 《临床肿瘤学医学期刊》 2006年第2期

Therapy,PhaseI,IITrialAssessingBortezomibandMelphalanCombinationTherapyfortheTreatmentofPatientsWithRelapsedorRefractoryMultipleMyeloma

    百拇医药网 http://www.100md.com/html/DirDu/2007/04/10/41/64/89.htm

您现在查看是摘要页，全文长 33583 字符。